Groupama Asset Managment Increases Holdings in UnitedHealth Group Incorporated $UNH

Groupama Asset Managment raised its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 3.5% during the third quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 64,882 shares of the healthcare conglomerate’s stock after buying an additional 2,203 shares during the quarter. Groupama Asset Managment’s holdings in UnitedHealth Group were worth $22,404,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the business. Investment Research Partners LLC bought a new stake in UnitedHealth Group in the third quarter valued at $554,000. Cambria Investment Management L.P. lifted its position in shares of UnitedHealth Group by 38.9% in the 3rd quarter. Cambria Investment Management L.P. now owns 1,570 shares of the healthcare conglomerate’s stock worth $542,000 after purchasing an additional 440 shares during the period. KERR FINANCIAL PLANNING Corp purchased a new position in shares of UnitedHealth Group during the third quarter valued at about $112,000. ARQ Wealth Advisors LLC purchased a new stake in UnitedHealth Group in the third quarter worth about $320,000. Finally, Manhattan West Asset Management LLC boosted its position in UnitedHealth Group by 1.2% during the 3rd quarter. Manhattan West Asset Management LLC now owns 10,217 shares of the healthcare conglomerate’s stock valued at $3,528,000 after acquiring an additional 123 shares in the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Price Performance

UNH opened at $284.03 on Thursday. UnitedHealth Group Incorporated has a 1 year low of $234.60 and a 1 year high of $606.36. The stock has a 50-day moving average price of $299.84 and a 200-day moving average price of $324.69. The firm has a market cap of $257.81 billion, a PE ratio of 21.53, a P/E/G ratio of 1.32 and a beta of 0.41. The company has a debt-to-equity ratio of 0.72, a current ratio of 0.79 and a quick ratio of 0.79.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Tuesday, January 27th. The healthcare conglomerate reported $2.11 earnings per share for the quarter, beating analysts’ consensus estimates of $2.09 by $0.02. The business had revenue of $113.73 billion during the quarter, compared to analyst estimates of $113.38 billion. UnitedHealth Group had a net margin of 2.69% and a return on equity of 14.79%. UnitedHealth Group’s revenue was up 12.3% compared to the same quarter last year. During the same period last year, the business earned $6.81 EPS. UnitedHealth Group has set its FY 2026 guidance at 17.750- EPS. Sell-side analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, March 17th. Shareholders of record on Monday, March 9th were paid a dividend of $2.21 per share. This represents a $8.84 annualized dividend and a yield of 3.1%. The ex-dividend date was Monday, March 9th. UnitedHealth Group’s dividend payout ratio (DPR) is currently 67.02%.

Analyst Ratings Changes

A number of research analysts have recently commented on the company. Piper Sandler restated an “overweight” rating on shares of UnitedHealth Group in a research note on Tuesday, January 27th. Evercore upgraded UnitedHealth Group to a “strong-buy” rating in a report on Tuesday, January 6th. Barclays reduced their target price on shares of UnitedHealth Group from $391.00 to $327.00 and set an “overweight” rating on the stock in a research report on Friday, January 30th. Oppenheimer lowered their price target on shares of UnitedHealth Group from $415.00 to $385.00 and set an “outperform” rating for the company in a research report on Wednesday, January 28th. Finally, Mizuho decreased their target price on shares of UnitedHealth Group from $430.00 to $350.00 and set an “outperform” rating for the company in a research note on Thursday, February 5th. One research analyst has rated the stock with a Strong Buy rating, seventeen have given a Buy rating, eight have issued a Hold rating and two have issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, UnitedHealth Group has a consensus rating of “Moderate Buy” and a consensus price target of $372.13.

UnitedHealth Group Profile

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.